RETINALGENIX TECHNOLOGIES INC.

Highlights RetinalGenix Technologies Inc.

Equities

RTGN

US76133Y1055

Market Closed - OTC Markets Other stock markets 17:47:02 22/02/2024 GMT			5-day change	1st Jan Change
3.5 ^USD	+12.90%		-.--%	+13.27%

05-20	RetinalGenix Technologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-01	RetinalGenix Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

RetinalGenix Technologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-20	CI
RetinalGenix Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-01	CI
RetinalGeniX?? Technologies Inc. Contracts with Medsan, Inc. to Provide Diagnostic Testing Services for Its Institutional Review Board to Conduct a Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration	12-26	CI
RetinalGenix Technologies Inc. Appoints Stephen Tannenbaum to the Business Advisory Board	11-28	CI
RetinalGenix Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
RetinalGeniX Technologies Inc. Announces the Submission of Two Provisional Patent Applications for Investigational Therapeutic Drugs	11-09	CI
RetinalGeniX Contracts With Avania CRO to Provide Guidance for Interactions With FDA on Development of Two Drug Therapies and the RetinalCam? Image Visualization Device	11-08	CI
RetinalGeniX Technologies Inc. Announces Institutional Review Board Approves to Conduct Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration	30/10/23	CI
RetinalGenix Technologies Inc. Appoints Fred Chasalow to the Medical Advisory Board of DNA-GPS	28/08/23	CI
RetinalGenix Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23	CI
RetinalGenix Technologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	18/05/23	CI
RetinalGenix Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	31/03/23	CI
RetinalGenix Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	17/11/22	CI
RetinalGenix Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	19/08/22	CI
RetinalGenix Technologies Inc. acquired DNA/GPS Inc. from Lawrence Perich for $14 million.	05/07/22	CI
RetinalGenix Technologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	13/05/22	CI
RetinalGenix Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	15/04/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer